Encompass Health COO sells 2,804 shares

Encompass Health Corp. executive vice president and chief operating officer Patrick William Tuer sold 2,804 shares of Encompass Health common stock in an open market transaction on February 10, 2026.

Rhea-AI Filing Summary

Encompass Health Corp. executive vice president and chief operating officer Patrick William Tuer sold 2,804 shares of Encompass Health common stock in an open market transaction on February 10, 2026. The shares were sold at a weighted average price of $107.62 per share, in multiple trades ranging from $107.55 to $107.73. Following this sale, Tuer directly beneficially owns 16,042 shares of Encompass Health common stock.

Insider Trade Summary

Net Seller: 2,804 shares

Net Sell 1 txn

Insider Tuer Patrick William

Role EVP, Chief Operating Officer

Sold 2,804 shs ($302K)

Type	Security	Shares	Price	Value
Sale	Encompass Health Common Stock	2,804	$107.62	$302K

Holdings After Transaction: Encompass Health Common Stock — 16,042 shares (Direct)

Footnotes (1)

1. F1. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.55 to $107.73, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for Patrick William Tuer?

Encompass Health (EHC) reported that EVP and COO Patrick William Tuer sold 2,804 shares of Encompass Health common stock. The transaction occurred on February 10, 2026 and was disclosed on a Form 4 insider trading report.

At what price did the Encompass Health (EHC) COO sell his shares?

The Encompass Health (EHC) COO sold his shares at a weighted average price of $107.62 per share. Individual trades occurred in a price range from $107.55 to $107.73, as disclosed in the Form 4 footnote.

How many Encompass Health (EHC) shares does Patrick William Tuer own after the sale?

After the reported sale, Patrick William Tuer beneficially owns 16,042 shares of Encompass Health common stock. These shares are listed as held with direct ownership in the Form 4 filing following the February 10, 2026 transaction.

What does the Form 4 footnote reveal about Encompass Health (EHC) share sale pricing?

The Form 4 footnote explains that the $107.62 figure is a weighted average price. The 2,804 shares of Encompass Health (EHC) stock were sold in multiple trades at prices between $107.55 and $107.73, inclusive, rather than at a single execution price.

What position does Patrick William Tuer hold at Encompass Health (EHC)?

Patrick William Tuer is identified as Executive Vice President and Chief Operating Officer of Encompass Health (EHC). His role is disclosed in the relationship section of the Form 4, which classifies him as an officer of the company.

Was the Encompass Health (EHC) COO’s transaction a purchase or a sale?

The transaction reported for Encompass Health (EHC) COO Patrick William Tuer was a sale of common stock. The Form 4 lists transaction code “S”, indicating an open market or private sale of 2,804 shares on February 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuer Patrick William

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/10/2026		S		2,804	D	$107.62(1)	16,042	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.55 to $107.73, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

	Patrick William Tuer	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.